CCRM and Affigen Partner to Develop Personalized Therapeutics for B-Cell Lymphoma, Leukemia
News
CCRM, a Canadian nonprofit that develops regenerative medicine technologies, and Affigen will collaborate on the development and commercialization of a closed platform that produces targeted therapies personalized for a patient’s ... Read more
Lymphoma Scare Turned Out to Be a Reaction to Tattoo Ink, Case Study Reports
News
Tattoo ink can generate a condition that mimics lymphoma, doctors at the Royal Prince Alfred Hospital in Australia discovered. A 30-year-old woman showed many of the signs of lymphoma. But ... Read more
Caring for Caregivers
Columns, Overcoming Adversity- a Column by Radiant Racheli
While I was going through treatment for Hodgkins, I became very conscious about the fact that my diagnosis did not affect only me. As treatment progressed, I realized I was still ... Read more
How to Prepare for the Costs of Cancer Treatment
Explaining Chronic Illness: An Alternative to the Spoon Theory
FDA Gives Adcetris-Chemo Combo Breakthrough Therapy Status as First-Line Hodgkin Lymphoma Therapy
News
The U.S. Food and Drug Administration has granted Adcetris (brentuximab vedotin) Breakthrough Therapy Designation as a treatment with chemotherapy for patients with previously untreated advanced classical Hodgkin lymphoma. The designation, awarded ... Read more
Rituxan Seen to Benefit Mantle Cell Lymphoma Patients After Stem Cell Transplant
News
A Phase 3 trial of Rituxan (rituximab) as a maintenance therapy in adults with mantle cell lymphoma after a stem cell transplant found that the treatment improved survival rates over four years. ... Read more
How Cancer Affects Sexual Intimacy
Incysus Seeks FDA Approval to Start Blood Cancer Trials for Its γδ T-Cell Immunotherapy
News
Incysus has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) to start clinical development of its expanded and activated allogeneic gamma-delta (γδ) T-cell ... Read more
Gene Therapy-Based Cancer Treatment Delivers Promising Results in B-cell Malignancies, Study Shows
News
A gene therapy-based cancer treatment completely eliminated traces of tumor cells in 40 percent of patients with certain B-cell malignancies, according to data from a Phase 1/2a clinical trial. The study ... Read more
Autolus’ Trials Will Assess AUTO3 as Potential Therapy in Leukemia, Lymphoma Patients
News
Autolus has initiated two Phase 1/2 trials to test AUTO3, a new CAR T-cell therapy that targets two cancer proteins instead of one. The trials, AMELIA and ALEXANDER, will be ... Read more